Ovarian cancer: diagnostic, biological and prognostic aspects

Ovarian cancer remains the most lethal gynecologic malignancy, owing to late detection, intrinsic and acquired chemoresistance and remarkable heterogeneity. Despite optimization of surgical and chemotherapy protocols and initiation of clinical trials incorporating targeted therapy, only modest gains...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Women's Health 2014-09, Vol.10 (5), p.519-533
Hauptverfasser:	Davidson, Ben, Tropé, Claes G
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer therapies Care and treatment Chemotherapy chemotherapy resistance Clinical medicine Development and progression Diagnosis Disclosure Disease Disease Progression DNA repair Drug Resistance, Neoplasm Education Female Hospitals Humans Medical research Medicine microenvironment Molecular Targeted Therapy - methods Morphology Mutation Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - prevention & control Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Ovarian Neoplasms - prevention & control Participation Physicians prognosis progression Studies Tumors Women's Health Womens health
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!